NO924323L - Nye hybridtransformerende vekstfaktorer - Google Patents

Nye hybridtransformerende vekstfaktorer

Info

Publication number
NO924323L
NO924323L NO92924323A NO924323A NO924323L NO 924323 L NO924323 L NO 924323L NO 92924323 A NO92924323 A NO 92924323A NO 924323 A NO924323 A NO 924323A NO 924323 L NO924323 L NO 924323L
Authority
NO
Norway
Prior art keywords
growth factors
new hybrid
transforming growth
hybrid
tgf
Prior art date
Application number
NO92924323A
Other languages
English (en)
Norwegian (no)
Other versions
NO924323D0 (no
Inventor
Gary Kent Mcmaster
David Cox
Nico Cerletti
Jochen Kuhla
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO924323D0 publication Critical patent/NO924323D0/no
Publication of NO924323L publication Critical patent/NO924323L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO92924323A 1991-11-11 1992-11-10 Nye hybridtransformerende vekstfaktorer NO924323L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810870 1991-11-11

Publications (2)

Publication Number Publication Date
NO924323D0 NO924323D0 (no) 1992-11-10
NO924323L true NO924323L (no) 1993-05-12

Family

ID=8208899

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924323A NO924323L (no) 1991-11-11 1992-11-10 Nye hybridtransformerende vekstfaktorer

Country Status (12)

Country Link
EP (1) EP0542679A1 (ref)
JP (1) JPH05306297A (ref)
KR (1) KR930010177A (ref)
AU (1) AU2738392A (ref)
CA (1) CA2082450A1 (ref)
FI (1) FI925086A7 (ref)
IL (1) IL103684A0 (ref)
MX (1) MX9206456A (ref)
NO (1) NO924323L (ref)
NZ (1) NZ245047A (ref)
TW (1) TW240231B (ref)
ZA (1) ZA928647B (ref)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5436228A (en) * 1990-12-12 1995-07-25 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5824647A (en) * 1990-12-12 1998-10-20 Postlethwaite; Arnold E. Chemotactic wound healing peptides
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
EP0833624B1 (en) 1995-06-07 2007-11-07 Poniard Pharmaceuticals, Inc. Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
ES2226414T3 (es) 1998-06-10 2005-03-16 Biognostik Gesellschaft Fur Biomolekulare Diagnostik Mbh Estimulacion del sistema inmunitario.
WO2002012336A2 (en) * 2000-08-09 2002-02-14 Curis, Inc. TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US20060019916A1 (en) * 2004-04-02 2006-01-26 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for inducing IL-10 responses
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
CA2005120A1 (en) * 1988-12-15 1990-06-15 Anthony F. Purchio Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta

Also Published As

Publication number Publication date
IL103684A0 (en) 1993-04-04
TW240231B (ref) 1995-02-11
MX9206456A (es) 1993-07-01
NZ245047A (en) 1995-04-27
FI925086A0 (fi) 1992-11-09
FI925086L (fi) 1993-05-12
NO924323D0 (no) 1992-11-10
CA2082450A1 (en) 1993-05-12
ZA928647B (en) 1993-06-21
EP0542679A1 (en) 1993-05-19
KR930010177A (ko) 1993-06-22
FI925086A7 (fi) 1993-05-12
AU2738392A (en) 1993-05-13
JPH05306297A (ja) 1993-11-19

Similar Documents

Publication Publication Date Title
NO924323L (no) Nye hybridtransformerende vekstfaktorer
RU2010105646A (ru) Способ регенерации ткани
NO940597L (no) Isolering, vekst, differensiering og genslöyd på menneskers muskelceller
AU2293795A (en) Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth (in vivo), utilizing amphipathic peptides
WO2000006703A3 (en) Inhibition of graft versus host disease
US20030202965A1 (en) Methods and compositions for the preparation of cell transplants
Drąg-Zalesińska et al. A new betulin derivative stimulates the synthesis of collagen in human fibroblasts stronger than its precursor
EP1405906A4 (en) SCHWANN CELLS FROM INTERSTITIAL MYELOID CELLS
Liu et al. Laparoscopic harvest and free transplantation of great omentum flap for extensive tissue defects in complex wounds
WO2004011631A3 (en) Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
ES2150902T3 (es) Procedimientos para potenciar la cicatrizacion de heridas y la reparacion de tejidos.
CN102172337B (zh) 具有皮脂腺样结构的组织工程皮肤及其制备方法
Kwon et al. Regeneration of Chronic Rotator Cuff Tear in a Rabbit Model: Synergetic Benefits of Human Umbilical Cord Blood‐Derived Mesenchymal Stem Cells, Polydeoxyribonucleotides, and Microcurrent Therapy
Chrapusta et al. A comparative analysis of advanced techniques for skin reconstruction with autologous keratinocyte culture in severely burned children: own experience
CN113713176B (zh) 一种水凝胶及其制备方法与应用
Cebrián et al. Comparative study of the use of electromagnetic fields in patients with pseudoarthrosis of tibia treated by intramedullary nailing
Fu Skin ulcers in lower extremities: the epidemiology and management in China
CA2332935A1 (en) A method for inducing production of growth factors
Morrone et al. In Vitro Experimental Research of Rabbit Condrocytes Biostimulation with Diode Laser Ga-Ai-As: A Preliminary Study
CN104906633A (zh) 一种可注射型骨修复材料及其制备方法
RU2811662C1 (ru) Способ стимуляции заживления ожоговых травм в эксперименте
Qian et al. New Technology and Tissue Repair and Regeneration (3): Application of Other New Technologies in Tissue Repair and Regeneration
Eskandar Stem cells, PRP, and bioprinting--Advancements in regenerative medicine for orthopedic disorders.
Lay et al. Viability of human dental pulp stem cells: The potential of L-arginine-based culture media
Aldana et al. Platelet-Rich Plasma in Split-Thickness Skin Graft Donor Sites: A Narrative Review of Healing Outcomes and Pain Reduction